BioStem Technologies Initiates Nationwide Launch of Vendaje AC(R) with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions

POMPANO BEACH, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces it will initiate a nationwide launch of Vendaje AC(R) with Venture Medical, LLC, the Company’s exclusive sales and marketing partner. The launch […]

METRO Inc. Completes the transformation of its supply chain with an investment of nearly a $1 billion

Fresh Distribution Centre in Toronto now open METRO Inc. (“METRO”) (TSX: MRU) announced today the inauguration of its automated distribution centre for fresh products in Toronto which marks the completion of nearly billion-dollar investment in the modernization of its supply chain. With the new Toronto Fresh distribution centre now fully in operation, the final milestone

Bitfarms Nominates Andrew J. Chang for Election to the Board of Directors

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated March 8, 2024, to its short form base shelf prospectus dated November 10, 2023. TORONTO, Ontario and BROSSARD, Québec, Oct. 29, 2024 (GLOBE NEWSWIRE) — Bitfarms Ltd. (NASDAQ/TSX: BITF) (“Bitfarms” or the “Company”), a global leader in vertically

BioXcel Therapeutics to Present at ThinkEquity Conference

NEW HAVEN, Conn., Oct. 29, 2024 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that Vimal Mehta, Ph.D., CEO, and Vincent J. O’Neill, M.D., Executive Vice President, Chief of Product Development and Medical Officer, will present at the ThinkEquity Conference in

REMINDER / GDI INTEGRATED FACILITY SERVICES INC.: FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2024

RELEASE DATE AND CONFERENCE CALL GDI Integrated Facility Services Inc. (“GDI”) (TSX: GDI) will release its financial results for the third quarter ended September 30,2024, on Tuesday, November 12, 2024, following market close. GDI will hold a conference call on Wednesday, November 13, 2024, at 9:00 a.m. (Eastern Time) to discuss its financial and operating

Perspective Therapeutics to Participate in Upcoming Investor Conferences in November

SEATTLE, Oct. 29, 2024 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the following upcoming

Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024

NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced seven presentations from across its broad portfolio of innovative neuroscience products and product candidates at Psych Congress 2024, being held Oct. 29 –

Yankee Candle® Announces Expansion into Canada

The leading home fragrance brand celebrates a major market expansion as part of the parent company, Newell Brands, corporate strategy to grow in top international markets. The Yankee Candle Company, Inc., the leader in home fragrance and part of the Newell Brands global portfolio of brands, announced the expanded availability of Yankee Candle products to

Beneficient to Present at the LD Micro Main Event XVII on October 30 in Los Angeles

DALLAS, Oct. 29, 2024 (GLOBE NEWSWIRE) — Beneficient (Nasdaq: BENF) (“Ben” or the “Company”), a technology-enabled financial services holding company, today announced that it will be presenting at the LD Micro Main Event XVII investor conference to be held October 28-30, 2024 in Los Angeles. As part of the conference, the Company will conduct a

Macerich Refinances Top-Performing Queens Center at Favorable Terms

5.37% Fixed Rate for 5 Years, Interest Only, on $525M Loan Lowest Refi Rate Achieved by Company in Past 5 Years SANTA MONICA, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) — Macerich (NYSE: MAC), one of the nation’s leading owners, operators and developers of major retail properties in top markets, today announced that it has refinanced

Scroll to Top